He has loved computers since he got the Lenovo G570 in 2012. Abhishek holds a master's degree in computer applications and began his writing career in 2018. He loves writing how-to articles, listicles ...

At the company’s annual September product event, Apple also demonstrated its work on artificial intelligence and other new devices. By Kalley Huang Reporting from Cupertino, Calif. Apple introduced a ...

Apple on Wednesday unveiled its first foldable phone, called the iPhone Duo, a device that opens like a book into a wide screen. The announcement marks the biggest change to the iPhone since it was ...

Dr. Jannae White has spent her career turning a mouthful of a diagnosis into something patients can understand and act on. A certified registered nurse practitioner at Ascension St. Agnes Heart ...

And in light of AstraZeneca and Ionis' ESC presentation, analysts were largely confident that Alnylam’s next-gen siRNA prospect, nucresiran could still succeed in its own ongoing phase 3 test. (iStock ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. AstraZeneca on Friday detailed the ...

The ATTR-CM market grew over 40% last year to pass the $7 billion sales mark, Royalty noted. (imagedepotpro/iStock/Getty Images Plus) Royalty Pharma has secured a ...

Apple's iOS 27 recovery screen offers iPhone and iPad users a better first step when a device won't start, especially without a computer nearby. Here's how to open it, which repair option to try first ...

AT&T is raising a monthly administrative fee on phone bills next month. Starting Aug. 5, the telecommunications company is raising the monthly cost of its Administrative & Regulatory Cost Recovery Fee ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

AstraZeneca and Ionis Pharmaceuticals disclosed Thursday morning that their gene-silencing drug Wainua (eplontersen) failed the largest clinical trial ever conducted in transthyretin-mediated amyloid ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — In a blow to its ...